Kemnay Advisory Services’s Merck MRK Stock Holding History

Kemnay Advisory Services’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$134K	Buy	1,043 +96	+10%	+$11.2K	0.02%	110
2026 Q1	$114K	Sell	947 -43	-4%	-$4.96K	0.02%	89
2025 Q4	$104K	Buy	+990	New	+$92.9K	0.02%	152

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kemnay Advisory Services's MRK Position: Q2 2026 in Review

Kemnay Advisory Services increased its Merck (MRK) stake by 10% in Q2 2026, buying an estimated $11.2K and bringing the position to 1,043 shares worth $134K. The position accounts for 0.02% of the portfolio, ranked #110.

Kemnay Advisory Services first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Kemnay Advisory Services held 1,043 shares of Merck worth $134K as of Q2 2026.
Kemnay Advisory Services bought 96 Merck shares in Q2 2026, an estimated $11.2K.
Merck made up 0.02% of Kemnay Advisory Services's portfolio in Q2 2026, its #110 holding.
Kemnay Advisory Services first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.